Streeter A J, Timbrell J A
Drug Metab Dispos. 1983 May-Jun;11(3):179-83.
Hydralazine was metabolized in vitro to a reactive metabolite(s) which bound to microsomal protein. The binding was dependent on mixed function oxidase activity, was proportional to time and microsomal protein concentration, and was not removed by acid washing. The apparent Km was 3.55 X 10(-5) M and the Vmax was 0.342 nmol/mg protein/min. Binding was inhibited by carbon monoxide and required oxygen and enzyme activity. Microsomes from animals pretreated with 3-methylcholanthrene showed a slight but significant increase in covalently bound hydralazine metabolite(s) whereas piperonyl butoxide treatment significantly reduced this binding. Glutathione, cysteine, and N-acetylcysteine all reduced the binding when added to incubations. Therefore, hydralazine is metabolized by the microsomal enzymes to a metabolite(s) capable of reacting covalently with cellular macromolecules.
肼屈嗪在体外被代谢为一种与微粒体蛋白结合的活性代谢物。这种结合依赖于混合功能氧化酶活性,与时间和微粒体蛋白浓度成正比,且不能通过酸洗去除。表观米氏常数为3.55×10⁻⁵ M,最大反应速度为0.342 nmol/mg蛋白/分钟。一氧化碳可抑制结合,且结合需要氧气和酶活性。用3-甲基胆蒽预处理的动物的微粒体显示共价结合的肼屈嗪代谢物略有但显著增加,而胡椒基丁醚处理则显著降低这种结合。当添加到孵育体系中时,谷胱甘肽、半胱氨酸和N-乙酰半胱氨酸均能降低结合。因此,肼屈嗪被微粒体酶代谢为一种能够与细胞大分子发生共价反应的代谢物。